Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Jia

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy Oncolytics|November 2, 2022
Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3Huitao Liu, Amirhossein Bahreyni, Yasir Mohamud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 15, 1996
Spontaneous discharge and peripherally evoked orofacial responses of trigemino-thalamic tract neurons during wakefulness and sleepB E Cairns, S A McErlane, M C Fragoso, et al.
Gene Therapy|August 6, 2003
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cellsC-T Yang, J Song, X Bu, et al.
Canadian Journal of Physiology and Pharmacology|September 25, 2004
Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapyWilliam W-G Jia, Xuexian Bu, Don Philips, et al.
Anticancer Research|September 15, 2005
Oncolytic herpesvirus with secretable angiostatic proteins in the treatment of human lung cancer cellsCheng-Ta Yang, Yu-Chin Lin, Chun-Liang Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumorsCleo Y F Lee, Luke X X Bu, Arrigo DeBenedetti, et al.
Virology Journal|July 24, 2013
MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cellsJhy-Ming Li, Kuo-Chin Kao, Li-Fu Li, et al.
Molecular Therapy Oncolytics|March 4, 2020
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|February 12, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|August 30, 2019
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against <i>KRAS</i>-Mutant Lung AdenocarcinomaHaoyu Deng, Huitao Liu, Tanya de Silva, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy Oncolytics|November 2, 2022
Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3Huitao Liu, Amirhossein Bahreyni, Yasir Mohamud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 15, 1996
Spontaneous discharge and peripherally evoked orofacial responses of trigemino-thalamic tract neurons during wakefulness and sleepB E Cairns, S A McErlane, M C Fragoso, et al.
Gene Therapy|August 6, 2003
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cellsC-T Yang, J Song, X Bu, et al.
Canadian Journal of Physiology and Pharmacology|September 25, 2004
Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapyWilliam W-G Jia, Xuexian Bu, Don Philips, et al.
Anticancer Research|September 15, 2005
Oncolytic herpesvirus with secretable angiostatic proteins in the treatment of human lung cancer cellsCheng-Ta Yang, Yu-Chin Lin, Chun-Liang Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumorsCleo Y F Lee, Luke X X Bu, Arrigo DeBenedetti, et al.
Virology Journal|July 24, 2013
MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cellsJhy-Ming Li, Kuo-Chin Kao, Li-Fu Li, et al.
Molecular Therapy Oncolytics|March 4, 2020
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|February 12, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|August 30, 2019
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against <i>KRAS</i>-Mutant Lung AdenocarcinomaHaoyu Deng, Huitao Liu, Tanya de Silva, et al.
Pageof 2